NASDAQ · Financial Statements

Utah Medical Products, Inc. (UTMD) Financial Statements

$74.23 NASDAQ: UTMD Market Cap $235.59M

Utah Medical Products, Inc. most recently reported annual revenue of $39.0M, net profit of $11.0M. Revenue declined at an average annual rate of 1.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Utah Medical Products, Inc.: Revenue rose from $39.0M in 2016 to $39.0M in 2025, a change of +0.0% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 41.2% to 29.6%, a shift of -11.6 percentage points; the most recent year shows net profit of $11.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$39.0M$41.0M$42.0M$47.0M$42.0M$49.0M$52.0M$50.0M$41.0M$39.0M
Operating Expenses$23.0M$22.0M$23.0M$29.0M$28.0M$30.0M$32.0M$33.0M$27.0M$27.0M
Operating Profit$16.0M$19.0M$19.0M$18.0M$14.0M$19.0M$20.0M$17.0M$14.0M$11.0M
Operating Margin41.2%45.9%44.5%37.6%32.5%38.5%37.9%33.4%33.2%29.6%
Other Income$0$0$1.0M$0$0$0$1.0M$3.0M$3.0M$3.0M
Interest$0$0$0$0$0$0$0$0$0$0
Depreciation$3.0M$3.0M$3.0M$7.0M$7.0M$7.0M$7.0M$6.0M$3.0M$3.0M
Profit Before Tax$16.0M$19.0M$19.0M$18.0M$14.0M$19.0M$21.0M$20.0M$17.0M$14.0M
Tax$26.1M$55.4M$4.7M$17.6M$22.0M$22.4M$20.3M$17.2M$17.4M$20.0M
Net Profit$12.0M$9.0M$19.0M$15.0M$11.0M$15.0M$16.0M$17.0M$14.0M$11.0M
EPS$3.22$2.28$4.95$3.94$2.94$4.04$4.52$4.57$3.96$3.48
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$13.0M$12.0M$11.0M$10.0M$10.0M$9.0M$10.0M$10.0M$10.0M$9.0M$9.0M$9.0M
Operating Expenses$9.0M$8.0M$7.0M$7.0M$7.0M$6.0M$7.0M$7.0M$7.0M$7.0M$6.0M$6.0M
Operating Profit$4.0M$4.0M$4.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$2.0M$3.0M$3.0M
Operating Margin31.7%32.0%34.2%33.1%33.4%32.0%32.5%32.1%26.6%27.0%29.4%31.1%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$5.0M$5.0M$5.0M$4.0M$4.0M$4.0M$4.0M$4.0M$3.0M$3.0M$3.0M$3.0M
Tax$17.7M$14.6M$17.6M$18.0M$14.7M$19.7M$21.2M$20.5M$20.5M$17.4M$18.2M$18.3M
Net Profit$4.0M$4.0M$4.0M$3.0M$4.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M
EPS$1.08$1.18$1.09$0.98$1.02$0.86$0.92$0.94$0.82$0.80$0.82$0.84

Over the 10 years reported for Utah Medical Products, Inc., cash stood at $86.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 32.67 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$77.0M$93.0M$100.0M$110.0M$112.0M$116.0M$124.0M$135.0M$123.0M$123.0M
Current Assets$35.0M$49.0M$61.0M$55.0M$62.0M$73.0M$90.0M$106.0M$96.0M$98.0M
Cash$26.0M$40.0M$51.0M$43.0M$52.0M$61.0M$75.0M$93.0M$83.0M$86.0M
Inventory$5.0M$5.0M$5.0M$7.0M$6.0M$7.0M$9.0M$10.0M$9.0M$8.0M
Receivables$3.0M$4.0M$4.0M$5.0M$4.0M$5.0M$6.0M$3.0M$4.0M$4.0M
Fixed Assets$10.0M$12.0M$10.0M$11.0M$11.0M$11.0M$10.0M$11.0M$10.0M$10.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$0$0$0$0
Other Assets$13.0M$14.0M$14.0M$14.0M$14.0M$14.0M$13.0M$14.0M$14.0M$14.0M
Total Liabilities$7.0M$15.0M$11.0M$9.0M$9.0M$8.0M$10.0M$7.0M$5.0M$3.0M
Current Liabilities$3.0M$5.0M$5.0M$3.0M$4.0M$4.0M$6.0M$5.0M$4.0M$3.0M
Borrowings$0$0$0$0$0$0$0$0$0$0
Other Liabilities$7.0M$15.0M$11.0M$8.0M$9.0M$8.0M$9.0M$7.0M$5.0M$3.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$69.0M$78.0M$89.0M$101.0M$103.0M$107.0M$114.0M$128.0M$117.0M$119.0M

For Utah Medical Products, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $14.0M; free cash flow was positive in 9 of 10 years; financing activities used $8.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$15.0M$17.0M$17.0M$17.0M$20.0M$21.0M$21.0M$22.0M$15.0M$15.0M
Investing Cash Flow$-7.0M$-3.0M$0$-43.0M$-2.0M$-1.0M$-2.0M$-1.0M$0$-1.0M
Financing Cash Flow$-2.0M$-3.0M$-1.0M$0$-7.0M$1.0M$-2.0M$0$-20.0M$-8.0M
Net Cash Flow$3.0M$14.0M$11.0M$-8.0M$9.0M$9.0M$14.0M$18.0M$-10.0M$3.0M
Free Cash Flow$11.0M$15.0M$16.0M$-4.0M$19.0M$21.0M$20.0M$22.0M$15.0M$14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.84
EV / EBITDA16.11
FCF Yield4.85%
Quick Ratio44.27
Interest Coverage—
Return 1Y12.51%
Return 3Y-28.87%
Return 5Y-12.28%

Utah Medical Products, Inc. (UTMD) financials — frequently asked questions

What is Utah Medical Products, Inc.'s annual revenue?

Utah Medical Products, Inc. (UTMD) reported annual revenue of $39.0M in its most recent fiscal year.

What is Utah Medical Products, Inc.'s net profit?

Utah Medical Products, Inc. (UTMD) reported net profit of $11.0M in its most recent fiscal year.

What is UTMD EV/EBITDA?

Utah Medical Products, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 16.11.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
UTMD Overview UTMD Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.